Crimson Publishers Publish With Us Reprints e-Books Video articles


Developments in Anaesthetics & Pain Management

Echinocandin in an Intensive Care Unit: A Pearl’s Peril in Intra Abdominal Post-Operative Carew?

  • Open or Close Alexandra E Lee1 and Vikram Anumakonda2*

    1Senior Honorary Clinical Lecturer, University of Birmingham, UK

    2Consultant Physician, Critical Care Medicine, UK

    *Corresponding author: Vikram Anumakonda, Consultant Physician, Critical Care Medicine, Consultant Physician, Critical Care Medicine, Pensnett Road, Dudley DY1 2HQ

Submission: December 18, 2017; Published: July 19, 2018

Volume1 Issue4
July 2018


Anidulafungin is an echinocandin armamentarium antifungal drug, indicated for use in invasive candidiasis [1]. The mechanism of action is by preventing the synthesis of fungal cell walls [2], However identification and initiation of treatment for invasive candidiasis is difficult and challenging for intensivists in a cohort of critically ill patients during post-operative period. To our knowledge this is the first documented case of such side effects associated with the use of Anidulafungin.

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137